
Loading, please wait...

Loading, please wait...

Toxicologic pathologists must choose the right methodology for severity scoring histopathology to ensure high-quality preclinical data. Standard conventions in the field often involve either an absolute or a relative approach. While both methods are technically legitimate, they serve different study objectives. Selecting the appropriate technique affects the objectivity and replicability of study results.
Relative scoring often proves more expedient for researchers. This method tends to generate fewer diagnoses in both treated groups and control animals. Consequently, it streamlines the data interpretation process. However, this approach relies heavily on comparing treated tissues against concurrent controls. This dependency can sometimes obscure subtle findings or introduce variability if control baseline tissues differ between studies.
Furthermore, the absolute approach offers distinct advantages for regulatory submissions. It provides superior objectivity and precision by using fixed criteria. Therefore, external reviewers can easily replicate the findings. Moreover, absolute scoring enhances transparency, which is vital for long-term safety assessments. Pathologists who use this method create a more robust data set that remains consistent across different toxicological investigations.
Notably, the choice depends on the specific requirements of the drug development program. In early-stage screening, a relative approach might suffice for speed. Conversely, late-stage studies often demand the precision of absolute scoring. Understanding these ramifications is essential for any professional involved in histopathologic data analysis.
Absolute scoring evaluates tissue findings based on fixed, pre-defined criteria. Conversely, relative scoring assesses findings in treated animals specifically in comparison to the concurrent control group.
The absolute method is considered more objective. Because it relies on external standards rather than shifting control benchmarks, it ensures higher replicability.
Regulatory agencies value the transparency and precision of the absolute approach. This method allows for easier cross-study comparisons and third-party verification of findings.
Disclaimer: This content is for informational and educational purposes only. It is not intended to provide specific medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Wolf JC et al. Absolute Versus Relative Approaches to Severity Scoring of Histopathologic Findings in Pre-Clinical Toxicology Studies: What's the Difference, and How, When, and Why This Matters. Toxicol Pathol. 2026 May 10. doi: 10.1177/01926233261445397. PMID: 42106935.
Crissman JW et al. Best practices guideline: toxicologic histopathology. Toxicol Pathol. 2004 Jan-Feb;32(1):126-31. doi: 10.1080/01926230490268756.
Mann PC et al. Use of Severity Grades to Characterize Histopathologic Changes. Toxicol Pathol. 2018 Apr;46(3):256-265. doi: 10.1177/0192623318761348.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Expert review on absolute vs. relative severity scoring in toxicologic pathology, highlighting the impact on data transparency and regulatory compliance....
5 months ago

A breakthrough study evaluated H5N1 transmission efficiency across mammalian isolates. Researchers discovered that human-derived D1.1 harboring the PB2 D701N mutation spread efficiently in ferrets, unlike strains carrying PB2 E627K. This finding highlights critical genetic markers for zoonotic surveillance.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today